In today’s shifting economic and regulatory environment, strong legal strategy is vital to navigating uncertainty and seizing opportunity in biomedical industry. This session begins with two mini-talks on legal strategies in cross-border mergers and acquisitions and the trends of biomedical IPOs in Hong Kong and U.S. Building on these perspectives, a panel of veteran lawyers from Fox Rothschild, THC Lawyers and Sarepta Therapeutics will discuss how expertise across corporate, regulatory, and intellectual property law can be leveraged to create resilient, forward-looking strategies.

Moderator:
Wansheng Jerry Liu, PhD JD, Partner, Fox Rothschild

Panelists:
Gerard P. Norton, PhD JD, Partner, Fox Rothschild - Mini-Talk: Legal Strategies in Cross-Border Mergers and Acquisitions
Ran He, PhD JD, Founder, THC Lawyers - Mini-Talk: Trend of Biomedical IPOin Hong Kong and US Capital Markets
Tamar R. Gubins, JD, Partner, Fox Rothschild
Peng Sun, PhD JD, Senior Director, Senior Patent Counsel, SareptaTherapeutics